MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the MiNK Therapeutics' First Quarter 2024 Conference Call and Webcast. [Operator Instructions]. Please note this event is being recorded.
Mink Therapeutics Inc. (INKT)
Market is closed
News
- Displaying 6
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript
MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.15.
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the MiNK Therapeutics’ First Quarter 2023 Financial Results Call.
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to MiNK Therapeutics' Fourth Quarter and Full Year 2022 Conference Call and Webcast.
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2022 Earnings Call Transcript
Operator: Good morning, and welcome to MiNK Therapeutics' Third Quarter 2022 Conference Call and Webcast. All participants will be in a listen-only mode until the question-and-answer session.
Hedge Fund and Insider Trading News: Ian Wace, Pierre Andurand, Millennium Management, Three Arrows Capital, Lockheed Martin Corporation (LMT), PureBase Corporation (PUBC), and More
It's not just Ken Griffin who's hiring in Miami.
Billionaire Hedge Funds
